Skip to main content
. 2015 Aug 19;123(11):633–643. doi: 10.1002/cncy.21595

Table 1.

Generic Data Retrieved From the Studies

Reference Country Where EGFR Testing Was Performed No. of Cytologic Samples No. of Histologic Samples No. of Patients With Cytologic Samples
Allegrini 201228 Italy 108 None NA
Bellevicine 201429 Italy 362 None NA
Billah 20119 United States 209 None 209
Hlinkova 201310 Slovakia 679 156 679
Leslie 201411 Australia 168 142 168
Lozano 201112 Spain 150 None 150
Ma 201213 Hong‐Kong 269 None 269
Mallapelle 201314 Italy 305 294 305
Nakajima 201115 Japan 156 None 156
Navani 201216 United Kingdom 119 None 119
Pang 201217 United Kingdoma 165 505 165
Peters 201418 Australia 274b 655b 2012c
Proietti 201419 Italy 161 265 161
Rekhtman 201130 United States 128 None NA
Santis 201120 United Kingdom 131 None 131
Shi 201421 NAd 169 1313 169
Shiau 201422 Canada 513 1780 513
Stella 201323 Italy 134 None 134
Stigt 201324 Netherlands 126 None 126
Takano 200725 Japan 117 130 117
Wu 201426 China 434 101 434
Yamada 201227 Japan 122 22 122

Abbreviations: EGFR, epidermal growth factor receptor; NA, not available.

a

Samples were from various East Asian countries.

b

This number was based on 929 samples that had a specified biopsy type; there were 901 additional samples for which this information was not provided.

c

The total number is indicated, including histologic samples.

d

Information on EGFR testing performed in individual countries was not available, but samples originated from various countries, including China (and Hong‐Kong), India, the Philippines, Taiwan, Thailand, and Vietnam.